Hospital Testing and Treatment Protocol for Tuberculosis

Diagnostic Testing Protocol

The American Thoracic Society recommends obtaining three sputum specimens for microscopy, culture, and drug susceptibility testing, followed by a standard treatment regimen for drug-susceptible tuberculosis 1, 2
Obtain three sputum specimens, preferably early morning samples on separate days, as recommended by the Infectious Diseases Society of America 3
Collection should be performed in an airborne infection isolation (AII) room or sputum induction booth to prevent transmission, as recommended by the Centers for Disease Control and Prevention 4
For patients unable to produce sputum, consider sputum induction with hypertonic saline or bronchoscopy under appropriate infection control measures, as recommended by the American College of Chest Physicians 1

Acid-fast bacilli (AFB) microscopy should be completed within 24 hours of specimen collection, as recommended by the American Thoracic Society 2, 5
Nucleic acid amplification (NAA) testing should be completed within 48 hours to rapidly identify M. tuberculosis complex, as recommended by the Infectious Diseases Society of America 2, 5
Mycobacterial culture should be performed using both solid and liquid media systems, with results available within 14 days, as recommended by the American Society for Microbiology 2, 5

For drug-susceptible TB, administer a four-drug regimen consisting of isoniazid, rifampin, pyrazinamide, and ethambutol for 2 months, then isoniazid and rifampin for 4 additional months, as recommended by the American Thoracic Society 7, 8
Treatment should be extended to 9 months if 2-month culture remains positive, as recommended by the Centers for Disease Control and Prevention 1

Collect sputum specimens monthly until two consecutive specimens are culture-negative, as recommended by the American Thoracic Society 1
Perform monthly clinical evaluations to identify possible adverse effects and assess adherence, as recommended by the Infectious Diseases Society of America 1

Maintain respiratory isolation for patients with suspected or confirmed pulmonary TB until they are determined to be non-infectious, as recommended by the Centers for Disease Control and Prevention 9
A patient is considered non-infectious when receiving effective therapy, showing clinical improvement, and having three consecutive negative sputum AFB smears collected on different days, as recommended by the American Thoracic Society 9